An Integrated Preclinical Evaluation Of Dna-Repair Mechanisms In Determining Response To Peptide Receptor Radionuclide Therapy (Prrt) As A Guide To Patient Selection And For Development Of Novel Combination Therapies

| Funding period: 2018 - 2022

Active

Researchers